Ownership Submission
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL
|
OMB Number:3235-0104Expires:January 31, 2005Estimated average burden hours per response...0.5
|
|
1. Name and Address of Reporting Person *
|
Tade Brad L.
|
|
2. Date of Event Requiring Statement (Month/Day/Year)
2024-07-24
|
3. Issuer Name and Ticker or Trading Symbol
ADMA BIOLOGICS, INC. [ADMA]
|
(Last)
|
(First)
|
(Middle)
|
C/O ADMA BIOLOGICS, INC. , 5800 PARK OF COMMERCE BLVD. NW
|
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
|
_____ 10% Owner
|
_____ Officer (give title below)
|
_____ Other (specify below)
|
CFO and Treasurer /
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
(Street)
|
BOCA RATON
|
FL
|
33487
|
|
6. Individual or Join/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
Table I - Non-Derivative Securities Beneficially Owned
|
|
1.Title of Security
|
2. Amount of Securities Beneficially Owned
|
3. Ownership Form: Direct (D) or Indirect (I)
|
4. Nature of Indirect Beneficial Ownership
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
|
2. Date Exercisable and Expiration Date
|
3. Title and Amount of Securities Underlying Derivative Security
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
6. Nature of Indirect Beneficial Ownership
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
Reporting Owners
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Tade Brad L.
C/O ADMA BIOLOGICS, INC.
5800 PARK OF COMMERCE BLVD. NW
BOCA RATON, FL33487
|
|
|
CFO and Treasurer
|
|
Signatures
/s/ Brad L. Tade, by Adam S. Grossman as attorney-in-fact
|
2024-07-26
|
**Signature of Reporting Person
|
Date
|
Explanation of Responses:
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
(1)
|
Includes shares acquired in open market purchases and pursuant to the vesting of restricted stock units ("RSUs").
|
(2)
|
On June 26, 2023, the Issuer granted the reporting person 100,000 RSUs, 75,000 of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting. Of the 25,000 RSUs that vested on June 26, 2024, 9,838 shares were withheld by the Issuer to satisfy mandatory tax withholding requirements.
|
(3)
|
On February 26, 2024, the Issuer granted the reporting person 50,000 RSUs, all of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
See Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.